Blog

The Critical Link Between Blood Pressure and Glaucoma Management Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While elevated intraocular pressure (IOP) is a well-known risk factor, emerging research highlights another critical player in glaucoma progression: blood pressure (BP). Understanding the relationship between blood pressure and glaucoma can help in […]

Palatin’s PL9588 Shows Promising Glaucoma Treatment Data Exciting new developments in glaucoma treatment are emerging as Palatin Technologies reveals promising data for its investigational drug, PL9588. This novel therapy could offer a breakthrough for millions of patients suffering from glaucoma, a leading cause of irreversible blindness worldwide. With glaucoma affecting over 80 million people globally,

Remidio’s AI Tools for Glaucoma and AMD Gain CDSCO Approval The healthcare technology landscape is evolving rapidly, and artificial intelligence (AI) is at the forefront of this transformation. In a significant milestone, Remidio, a pioneering med-tech company, has secured approval from the Central Drugs Standard Control Organization (CDSCO) for its AI-powered diagnostic tools designed to

Early Signs and Treatment Options for Glaucoma You Should Know Glaucoma is a serious eye condition that can lead to irreversible vision loss if not detected and treated early. Often referred to as the “silent thief of sight,” glaucoma progresses slowly and may not present noticeable symptoms until significant damage has occurred. Understanding the early

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant milestone for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for the PER-001 glaucoma implant. The novel device, designed to provide sustained intraocular pressure (IOP) reduction, demonstrated both safety and efficacy in early-stage testing, offering

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma, often referred to as the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. While early detection and treatment can prevent severe vision loss, the high costs associated with glaucoma care create significant barriers for many patients. This article explores how financial constraints

Glaucoma Therapeutic Market Growth, Key Players, and 2025 Forecast The glaucoma therapeutic market is experiencing significant growth, driven by rising prevalence rates, technological advancements, and increasing awareness about early diagnosis and treatment. Glaucoma, a leading cause of irreversible blindness, affects millions worldwide, making effective therapeutics a critical area of focus for healthcare providers and pharmaceutical

50 Years of Ophthalmology Breakthroughs: Experts Reflect on Innovations Introduction Over the past five decades, ophthalmology has undergone a profound transformation, reshaping how eye diseases are diagnosed, treated, and prevented. From groundbreaking surgical techniques to advanced diagnostic tools, these innovations have restored and preserved vision for millions worldwide. In this article, we highlight the most

Comprehensive Guide to Screening, Diagnosing, and Treating Open Angle Glaucoma Open-angle glaucoma is one of the most common forms of glaucoma, affecting millions of people worldwide. Often called the “silent thief of sight,” it progresses slowly and without noticeable symptoms until significant vision loss occurs. Early detection and proper treatment are crucial to preventing irreversible